Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

The propeptide precursor proSAAS is involved in fetal neuropeptide processing and body weight regulation.

Morgan DJ, Wei S, Gomes I, Czyzyk T, Mzhavia N, Pan H, Devi LA, Fricker LD, Pintar JE.

J Neurochem. 2010 Jun;113(5):1275-84. doi: 10.1111/j.1471-4159.2010.06706.x. Epub 2010 Mar 26.

2.

ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet.

Terasaka N, Yu S, Yvan-Charvet L, Wang N, Mzhavia N, Langlois R, Pagler T, Li R, Welch CL, Goldberg IJ, Tall AR.

J Clin Invest. 2008 Nov;118(11):3701-13. doi: 10.1172/JCI35470. Epub 2008 Oct 16.

3.

Neuronatin: a new inflammation gene expressed on the aortic endothelium of diabetic mice.

Mzhavia N, Yu S, Ikeda S, Chu TT, Goldberg I, Dansky HM.

Diabetes. 2008 Oct;57(10):2774-83. doi: 10.2337/db07-1746. Epub 2008 Jun 30.

4.

Embryonic gene expression and pro-protein processing of proSAAS during rodent development.

Morgan DJ, Mzhavia N, Peng B, Pan H, Devi LA, Pintar JE.

J Neurochem. 2005 Jun;93(6):1454-62.

5.

Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice.

Molnar J, Yu S, Mzhavia N, Pau C, Chereshnev I, Dansky HM.

Circ Res. 2005 Jun 10;96(11):1178-84. Epub 2005 May 5.

PMID:
15879311
6.

Endothelin converting enzyme-2: a processing enzyme involved in the generation of novel neuropeptides.

Pan H, Mzhavia N, Devi LA.

Protein Pept Lett. 2004 Oct;11(5):461-9. Review.

PMID:
15544567
7.

Obesity and diabetes in transgenic mice expressing proSAAS.

Wei S, Feng Y, Che FY, Pan H, Mzhavia N, Devi LA, McKinzie AA, Levin N, Richards WG, Fricker LD.

J Endocrinol. 2004 Mar;180(3):357-68.

PMID:
15012590
8.

Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides.

Mzhavia N, Pan H, Che FY, Fricker LD, Devi LA.

J Biol Chem. 2003 Apr 25;278(17):14704-11. Epub 2003 Jan 30.

9.

Sequence-specific interaction of nascent antiterminator RNA with the zinc-finger motif of Escherichia coli RNA polymerase.

Sen R, King RA, Mzhavia N, Madsen PL, Weisberg RA.

Mol Microbiol. 2002 Oct;46(1):215-22.

10.

Processing of proSAAS in neuroendocrine cell lines.

Mzhavia N, Qian Y, Feng Y, Che FY, Devi LA, Fricker LD.

Biochem J. 2002 Jan 1;361(Pt 1):67-76.

11.

Identification of peptides from brain and pituitary of Cpe(fat)/Cpe(fat) mice.

Che FY, Yan L, Li H, Mzhavia N, Devi LA, Fricker LD.

Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9971-6. Epub 2001 Jul 31.

12.

ProSAAS processing in mouse brain and pituitary.

Mzhavia N, Berman Y, Che FY, Fricker LD, Devi LA.

J Biol Chem. 2001 Mar 2;276(9):6207-13. Epub 2000 Nov 27.

13.

Impaired prohormone convertases in Cpe(fat)/Cpe(fat) mice.

Berman Y, Mzhavia N, Polonskaia A, Devi LA.

J Biol Chem. 2001 Jan 12;276(2):1466-73.

14.

Defective prodynorphin processing in mice lacking prohormone convertase PC2.

Berman Y, Mzhavia N, Polonskaia A, Furuta M, Steiner DF, Pintar JE, Devi LA.

J Neurochem. 2000 Oct;75(4):1763-70.

15.

The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1.

Qian Y, Devi LA, Mzhavia N, Munzer S, Seidah NG, Fricker LD.

J Biol Chem. 2000 Aug 4;275(31):23596-601.

16.

Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing.

Fricker LD, McKinzie AA, Sun J, Curran E, Qian Y, Yan L, Patterson SD, Courchesne PL, Richards B, Levin N, Mzhavia N, Devi LA, Douglass J.

J Neurosci. 2000 Jan 15;20(2):639-48.

17.

Supplemental Content

Loading ...
Support Center